Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
 
 
 
  Blog Calendar  
 
SuMoTuWeThFrSa
  
1
2345
6
7
8
9
10
1112
13141516171819
20212223242526
2728293031  
 
  Archive  
 
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Raymond Anton, Medical University of South Carolina, Charleston, SC

Catasys Health - Saturday, August 01, 2009

Randomized, Stratified, Double-Blind, Placebo-Controlled Trial of Flumazenil and Gabapentin for the Treatment of Alcohol Dependence
Published in the Journal of Clinical Psychopharmacology, August 2009; 29(4):334-342.

 The OnTrak Medical Treatment Program achieved a significant reduction in use and cravings among members with symptoms of alcohol withdrawal (>6 CIWA) when compared to placebo.

Among members with more symptoms of alcohol withdrawal, the Prometa group experienced: ยป More



Comments (0) | Trackbacks (0) | Permalink


| 1 |

 
 
  Tags
 
Harold Urschel opiod-based heroin opioid overdose naloxone contract buprenorphine ER nicotine post-traumatic stress disorder placebo-controlled opioid abuse cocaine treatment reduction in craving recovery marijuana Catasys mental illness care coaching drug use depression screening opioid antagonist morphine randomized social network emergency room binge drinking reduction in use behavioral health care Health Care Utilization anxiety smoking painkillers oxycodone psychosocial chronic pain gabapentin behavioral health care services health insurance sugar drinking methamphetamine dependence alcohol OnTrak communication treatment primary care placebo drug treatment alcoholism prescriptions craving hydrocodone Opioid Treatment alcohol dependence hospitalizations identification meth substance use disorder drug addiction facebook alcohol drinking Co Occurring Disorders stratified recovery network trauma pain pills muscle relaxant Raymond Anton codeine hospital stimulants withdrawal narcotic percocet SD health insurance OxyContin medical costs methamphetamine Journal of Psychopharmacology diabetes methadone health plan stress ADHD substance dependence addict pain medication fentanyl overdose sobriety sober behavioral health vicodin drug abuse over-the-counter substances suboxone craving score data mining mental health cocaine flumazenil Opioid Medications ADD UnitedHealthcare substance dependence health insurance dependence issues substance dependence costs drug addicts addiction urine drug screen medical physician- patient relations pain killers relapse bipolar disorder opiod abuse double-blind opiates medical and behavioral costs relapse prevention behavioral healthcare cigarettes reducing craving prometa opioid high-utilizing depression predictive modeling vivitrol SD members addiction treatment CIWA opioid-drug interactions PTSD alcohol treatment behavioral healthcare services health reform Research Across America
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy
 
  Copyright © 2011 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025